Javascript must be enabled to continue!

Lymphoma

Non-Hodgkin lymphoma (NHL) - International Prognostic Index - Indolent lymphoma - Treatment of indolent lymphoma - Aggressive lymphomas - Initial treatment of aggressive lymphomas - Salvage therapy in aggressive lymphomas - Response criteria for lymphoma - Role of FDG-PET scanning in NHL diagnosis and treatment - CNS lymphoma - Hodgkin lymphoma (HL) - Treatment of HL

Oxford University Press

Drew Provan Trevor Baglin Inderjeet Dokal Johannes de Vos

Oxford Medicine Online

2015

Title: Lymphoma

Description:

Back

Related Results

Malignant Hematology

The hematologic neoplasms include lymphoproliferative disorders (eg, chronic lymphocytic leukemia [CLL]/small lymphocytic lymphoma [SLL], large granular lymphocyte ...

Combination chemotherapy

One of the major advances in haematology during the past six decades has been the development of combination chemotherapy. However, some would dispute the claim that combination ch...

Hodgkin Lymphoma

Hodgkin lymphoma (HL) is a malignant neoplasm of the lymphatic system. The malignant cell clone derives from germinal center B lymphocytes in ~98% of cases, the rest being of T-lym...

Principles of oncogenesis

It is obvious that the process of developing cancer—oncogenesis—is a multistep process. We know that smoking, obesity, and a family history are strong independent predictors of dev...

Non-Hodgkin Lymphoma

Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies originating from B- or T-lymphocytes and engaging lymphoid tissue. Clinically, NHL subtypes range from chronic...

Leukaemia

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) ...

Email:
Password:

Email: